Differential values of ki‐67 index and mitotic index of proliferating cell population. An assessment of cell cycle and prognosis in radiation therapy for cervical cancer

Cancer

Volumn 72, Issue 8, 1993, Pages 2401-2408

  Nakano, Takashi ^a   Oka, Kuniyuki ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

cervical cancer; growth fraction; Ki 67 index; mitotic index; prognosis; radiation therapy

Indexed keywords

MONOCLONAL ANTIBODY KI 67;

ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MITOSIS; PRIORITY JOURNAL; PROGNOSIS; RADIATION RESPONSE; TUMOR GROWTH; UTERINE CERVIX CANCER;

CELL CYCLE; CELL DIVISION; CERVIX NEOPLASMS; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MITOTIC INDEX; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0027373632     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19931015)72:8<2401::AID-CNCR2820720818>3.0.CO;2-D     Document Type: Article

References (37)

1. Implications of thymidine labeling index in the growth kinetics of human solid tumors
2. The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report
3. Can cell kinetic parameters predict the response of tumours to radiotherapy?
4. Flow cytofluorometric evidence for the differential radiore‐sponsiveness of aneuploid and diploid cervix tumours
5. DNA‐flow cytometry of squamous cell carcinomas from the human uterine cervix: the identification of prognostically different subgroups
6. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation
7. Cell cycle analysis of a cell proliferation‐associated human nuclear antigen defined by the monoclonal antibody Ki‐67
8. Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki‐67
9. Transition of Ki‐67 index of uterine cervical tumors during radiation therapy. Immunohistochemical study
10. The prognostic value of Ki‐67 immunostaining in non‐Hodgkin's lymphoma
11. Prognostic significance of the proportion of Ki‐67 positive cells in adult T‐cell leukemia
12. Ki‐67 immunostaining in human breast tumors and its relationship to prognosis
13. A comparative study of histopathology, hormone receptors, peanut lectin binding, Ki‐67 immunostaining, and nucleolar organizer region‐associated proteins in human breast cancer
14. Prognostic significance of Ki‐67 reactivity in soft tissue sarcomas
15. Carcinoma of the cervix uteri: an assessment of the relationship of tumour proliferation to prognosis
16. Growth fractions in human prostatic carcinoma determined by Ki‐67 immunostaining
17. Radiobiology and cell cycle
18. Heterogeneity of X‐ray cytotoxicity in proliferating and quiescent murine mammary carcinoma cells
19. High dose rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix: a 20‐year experience
20. Use of avidin‐biotin‐peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures
21. The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney. Ultrastructural cytochemistry by a new technique
22. Histological evaluation of effects of radiotherapy and chemotherapy for carcinomas
23. Design and analysis of randomized clinical trials requiring prolonged observation of each patient
24. Recovery from potentially lethal damage and recruitment time of noncycling clonogenic cells in 9L confluent monolayers and spheroids
25. Quiescence in 9L cells and correlation with radiosensitivity and PLD repair
26. A restriction point for control of normal animal cell proliferation
27. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long‐term survival
28. Cell proliferation and differentiation in squamous cancer
29. Relationship between labeling indices of Ki‐67 and BrdUrd in human malignant tumors
30. Thymidine labeling index and Ki‐67 growth fraction in lesions of the breast
31. Gray medal lecture: cell kinetics and radiation oncology
32. The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx
33. The hazard of accelerated tumor clonogen repopulation during radiotherapy
34. Accelerated repopulation in tumours and normal tissues